SPONSOR
Amsterdam UMC
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Submucosal Esophageal AdenocarcinomaBarrett EsophagusHigh-risk Mucosal Esophageal AdenocarcinomaStomach Neoplasm
Amsterdam UMC is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma, Stomach Neoplasm.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Amsterdam UMC
How many clinical trials has Amsterdam UMC sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Amsterdam UMC, of which 2 are actively recruiting participants. These trials cover conditions including Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Amsterdam UMC research focus on?
Amsterdam UMC clinical trials span Submucosal Esophageal Adenocarcinoma, Barrett Esophagus, High-risk Mucosal Esophageal Adenocarcinoma, Stomach Neoplasm. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Amsterdam UMC clinical trial?
To participate in a Amsterdam UMC trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Amsterdam UMC trials with current recruitment status updated daily.
Clinical Trials by Amsterdam UMC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology